Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19.

التفاصيل البيبلوغرافية
العنوان: Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19.
المؤلفون: Busch MH; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht., Timmermans SAMEG; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht., Van Kuijk SMJ; Dept. of Clinical Epidemiology and Medical Technology Assessment., Aendekerk JP; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht., Ysermans R; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht., Van Doorn DPC; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht., Potjewijd J; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht., Van de Poll MCG; Dept. Intensive Care Medicine., Van der Horst ICC; Dept. Intensive Care Medicine., Damoiseaux JGMC; Central Diagnostic Laboratory., Spronk HMH; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands; Thrombosis Expertise Center, Maastricht University Medical Center, Maastricht., Cate HT; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands; Thrombosis Expertise Center, Maastricht University Medical Center, Maastricht., Reutelingsperger CP; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht., Nagy M; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht., Van Paassen P; Dept. Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands; Dept. Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht. p.vanpaassen@maastrichtuniversity.nl.
المصدر: Haematologica [Haematologica] 2023 May 01; Vol. 108 (5), pp. 1417-1422. Date of Electronic Publication: 2023 May 01.
نوع المنشور: Letter; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
أسماء مطبوعة: Publication: 1999- : Pavia, Italy : Ferrata Storti Foundation
Original Publication: Pavia [etc.]
مواضيع طبية MeSH: COVID-19* , von Willebrand Diseases*, Humans ; von Willebrand Factor/metabolism ; Thrombin/metabolism ; Blood Coagulation ; Factor VIII/metabolism ; Patient Acuity
References: Sci Rep. 2021 May 17;11(1):10464. (PMID: 34001992)
Blood. 2020 Sep 3;136(10):1169-1179. (PMID: 32597954)
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6388-93. (PMID: 17405864)
Blood Adv. 2022 Jun 14;6(11):3367-3377. (PMID: 35235941)
J Biol Chem. 1991 Apr 25;266(12):7353-8. (PMID: 2019570)
J Clin Invest. 2020 Nov 2;130(11):6151-6157. (PMID: 32759504)
Cells. 2021 Jan 19;10(1):. (PMID: 33477776)
Circulation. 2020 Nov 3;142(18):1787-1790. (PMID: 32946302)
Thromb Haemost. 2022 Feb;122(2):240-256. (PMID: 35062036)
EBioMedicine. 2021 May;67:103382. (PMID: 34000623)
Blood. 2011 Aug 18;118(7):1952-61. (PMID: 21673343)
Blood. 2017 Feb 23;129(8):1021-1029. (PMID: 27919911)
PLoS One. 2020 Oct 29;15(10):e0241329. (PMID: 33119703)
Thromb Res. 2022 Jan;209:106-114. (PMID: 34922160)
Thromb Res. 2020 Jul;191:145-147. (PMID: 32291094)
المشرفين على المادة: 0 (von Willebrand Factor)
EC 3.4.21.5 (Thrombin)
9001-27-8 (Factor VIII)
تواريخ الأحداث: Date Created: 20221215 Date Completed: 20230503 Latest Revision: 20230504
رمز التحديث: 20230504
مُعرف محوري في PubMed: PMC10153543
DOI: 10.3324/haematol.2022.281693
PMID: 36519327
قاعدة البيانات: MEDLINE
الوصف
تدمد:1592-8721
DOI:10.3324/haematol.2022.281693